Skip to main content
. Author manuscript; available in PMC: 2020 Nov 6.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Aug 1;105(2):367–375. doi: 10.1016/j.ijrobp.2019.07.023

Fig. 3.

Fig. 3.

Kaplan-Meier overall survival (OS) curves after first stereotactic ablative radiotherapy (SAbR). (A) Favorable versus intermediate/unfavorable prognostic groups. (B) Clear cell renal cell carcinoma (RCC) versus non-clear cell RCC. (C) M0 versus M1. (D) Bone versus nonbone metastasis.